Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome H. Pang, C. Zhang, F. Liu, X. Gong, X. Jin, C. Su

Intraventricular hemorrhage treated with intraventricular fibrinolysis. A 10-year experience S. Castaño Ávila, E. Corral Lozano, A. Vallejo De La Cueva, J. Maynar Moliner, A. Martín López, F. Fonseca San Miguel, J.A. Urturi Matos, A. Manzano Ramírez

Parathyroid hormone, calcidiol, calcitriol and adverse events in the acute coronary syndrome P. Ramos Ruiz, L. Jaulent Huertas, M. Castañeda Sancirilo, J.J. Martínez Díaz, G. Clavel Ruipérez, L. García de Guadiana Romualdo, S. Wasniewski, M. Merelo Nicolás, I. García Escribano, F. Soria Arcos, J.A. Castillo Moreno, L. Consuegra Sánchez